{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:31:47Z","timestamp":1790285507328,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011057","name":"National Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004705","name":"King Mongkut's University of Technology Thonburi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vaccine.2024.04.087","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T09:38:05Z","timestamp":1714815485000},"page":"3733-3743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease"],"prefix":"10.1016","volume":"42","author":[{"given":"Aliyu","family":"Maje Bello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9650-5290","authenticated-orcid":false,"given":"Khuanjit","family":"Chaimongkolnukul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokwan","family":"Poomputsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phenjun","family":"Mekvichitsaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowaluck","family":"Maprang Roshorm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.087_b0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14760584.2018.1510326","article-title":"Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease","volume":"17","author":"Fang","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.087_b0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.087_b0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12250-020-00294-3","article-title":"From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD)","volume":"36","author":"He","year":"2021","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2024.04.087_b0020","first-page":"1","article-title":"Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand 11 Medical and Health Sciences 1103 Clinical Sciences","volume":"15","author":"Lerdsamran","year":"2018","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2024.04.087_b0025","first-page":"1","article-title":"Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.087_b0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3201\/eid2404.171298","article-title":"Emerging coxsackievirus A6 causing hand, foot and mouth disease","volume":"24","author":"Anh","year":"2018","journal-title":"Vietnam. Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.087_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0052432","article-title":"Comparative Genomic Analysis of Coxsackievirus A6 Strains of Different Clinical Disease Entities","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.087_b0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3201\/eid1904.121666","article-title":"Hand, foot, and mouth disease caused by Coxsackievirus A6, Thailand, 2012","volume":"19","author":"Puenpa","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.087_b0045","first-page":"18","article-title":"France: A large citywide, prospective observational study","volume":"2012","author":"Mirand","year":"2010","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.vaccine.2024.04.087_b0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16 Epidemiology, diagnosis, and vaccine","volume":"10","author":"Mao","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.04.087_b0055","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/ciu624","article-title":"Severe hand, foot, and mouth disease and coxsackievirus A6-Shenzhen, China","volume":"59","author":"Yang","year":"2014","journal-title":"Clin Infectious Diseases"},{"key":"10.1016\/j.vaccine.2024.04.087_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.02249","article-title":"Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease","volume":"8","author":"Cox","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.087_b0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/nsr\/nwv038","article-title":"Etiology, pathogenesis, antivirals and vaccines of hand, foot, and mouth disease","volume":"2","author":"Lei","year":"2015","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.vaccine.2024.04.087_b0070","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1074\/jbc.M111.301622","article-title":"Molecular Determinants of Enterovirus 71 Viral Entry","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biological Chem"},{"key":"10.1016\/j.vaccine.2024.04.087_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.04.087_b0080","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.087_b0085","doi-asserted-by":"crossref","unstructured":"Kiener TK, Jia Q, Meng T, Chow VTK, Kwang J. A Novel Universal Neutralizing Monoclonal Antibody against Enterovirus 71 That Targets the Highly Conserved \u201cKnob\u201d Region of VP3 Protein. PLoS Negl Trop Dis 2014;8. 10.1371\/journal.pntd.0002895.","DOI":"10.1371\/journal.pntd.0002895"},{"key":"10.1016\/j.vaccine.2024.04.087_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-13-287","article-title":"Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses","volume":"13","author":"Zhao","year":"2013","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.087_b0095","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.087_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01257-17","article-title":"A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles","volume":"92","author":"Chen","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.04.087_b0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2019.02.016","article-title":"Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice","volume":"164","author":"Dai","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2024.04.087_b0110","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2024.04.087_b0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An Inactivated Enterovirus 71 Vaccine in Healthy Children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.04.087_b0120","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2024.04.087_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-39299-8","article-title":"Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach","volume":"9","author":"Chauhan","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.087_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99642-w","article-title":"Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay","volume":"11","author":"Polyiam","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.087_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.785293","article-title":"Immunodominant and Neutralizing Linear B-Cell Epitopes Spanning the Spike and Membrane Proteins of Porcine Epidemic Diarrhea Virus","volume":"12","author":"Polyiam","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.087_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-40833-x","article-title":"In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases","volume":"9","author":"Shey","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.087_b0145","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: Property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2024.04.087_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0155340","article-title":"Overcoming the refractory expression of secreted recombinant proteins in mammalian cells through modification of the signal peptide and adjacent amino acids","volume":"11","author":"G\u00fcler-Gane","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.087_b0155","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0006-291X(02)00566-1","article-title":"Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression","volume":"294","author":"Barash","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2024.04.087_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0165659","article-title":"Immunodominant IgM and IgG Epitopes recognized by antibodies induced in enterovirus A71-Associated hand, foot and mouth disease patients","volume":"11","author":"Aw-Yong","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.087_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-422X-9-26","article-title":"Enterovirus 71 viral capsid protein linear epitopes: Identification and characterization","volume":"9","author":"Gao","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2024.04.087_b0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.micinf.2014.11.004","article-title":"Towards broadly protective polyvalent vaccines against hand, foot and mouth disease","volume":"17","author":"Liu","year":"2015","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.04.087_b0175","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.04.087_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-7-106","article-title":"Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection","volume":"7","author":"Chang","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2024.04.087_b0185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/bc970183n","article-title":"Liposomal formulations of synthetic MUC1 peptides: Effects of encapsulation versus surface display of peptides on immune responses","volume":"9","author":"Guan","year":"1998","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.vaccine.2024.04.087_b0190","first-page":"429","article-title":"In silico prediction of B-cell and T-cell epitopes of protective antigen of Bacillus anthracis in development of vaccines against anthrax","volume":"7","author":"Tahmoorespur","year":"2017","journal-title":"Iran J Appl Anim Sci"},{"issue":"336","key":"10.1016\/j.vaccine.2024.04.087_b0195","first-page":"2012","article-title":"Crystal Structure of Human Enterovirus 71 Pavel","volume":"2012","author":"Plevka","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.04.087_b0200","doi-asserted-by":"crossref","unstructured":"Lyu K, Wang G, He Y, Han J, Ye Q, Qin C, et al. Crystal Structures of Enterovirus 71 (EV71) Recombinant Virus Particles Provide Insights into Vaccine Design * 2015;71. 10.1074\/jbc.M114.624536.","DOI":"10.1074\/jbc.M114.624536"},{"key":"10.1016\/j.vaccine.2024.04.087_b0205","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/erv.10.49","article-title":"New flow cytometric assays for monitoring cell-mediated cytotoxicity","volume":"9","author":"Zaritskaya","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.087_b0210","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4049\/jimmunol.1301439","article-title":"VP2 Dominated CD4+ T Cell Responses against Enterovirus 71 and Cross-Reactivity against Coxsackievirus A16 and Polioviruses in a Healthy Population","volume":"191","author":"Tan","year":"2013","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.vaccine.2024.04.087_b0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imm.12235","article-title":"Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls","volume":"142","author":"Dang","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2024.04.087_b0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/vim.2007.0089","article-title":"Identification of Human CD4 + T-Cell Epitopes on the VP1 Capsid Protein of Enterovirus 71","volume":"21","author":"Foo","year":"2008","journal-title":"Viral Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T10:44:54Z","timestamp":1720867494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":44,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0264410X24005267"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier India Pvt Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}